Drawing for PORTON BIOPHARMA

USPTO serial 79396321

PORTON BIOPHARMA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
FLETCHER, TRACY L
Law office
TMO LAW OFFICE 115

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with PORTON BIOPHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use, food for babies; dietary supplements for humans and animals; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; pharmaceutical preparations and substances; injectable pharmaceutical compositions and preparations comprising compounds having asparaginase activity; pharmaceutical compositions and preparations for the treatment of leukaemia and malignant diseases in the blood forming organs.ACTIVE—
041Education; arrangement of conferences for educational purposes; arrangement of seminars, workshops and exhibitions for educational purposes; education services; education services relating to pharmacy; education services relating to medicine; advice relating to medical training; advisory services relating to training; advisory services relating to education; arranging and conducting of workshops; conducting instructional courses; conducting of educational seminars relating to medical matters; training courses relating to medicine; training courses relating to science; medical education services; medical training and teaching; medical tuition services; organisation of training courses; publication of books; writing of texts other than publicity texts; educational information and services; instructional services; providing continuing dental education courses; providing continuing medical education services; providing continuing nursing education courses; provision of educational services relating to health; provision of educational services relating to biological topics; provision of educational services relating to fitness; provision of educational information; provision of training; provision of training courses; provision of on-line electronic publications (not downloadable from the Internet); production of video-tapes for corporate use in corporate educational training; professional consultancy relating to education; publication of educational material; technological education services; training services for medical visitors; training services for nurses; training services relating to health and safety; arranging and conducting of workshops relating to biologics; arranging and conducting of workshops relating to biopharmaceuticals; arranging and conducting training relating to biologics; arranging and conducting training relating to biopharmaceuticals; arrangement of workshops for educational purposes.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 22, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Oct 22, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 22, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Apr 19, 2025MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 19, 2025ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 26, 2024RFNTREFUSAL PROCESSED BY IB—
Oct 3, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 3, 2024RFRRREFUSAL PROCESSED BY MPU—
Sep 28, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 27, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 25, 2024DOCKASSIGNED TO EXAMINER—
Jun 11, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 11, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 24, 2024LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
May 23, 2024SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance